With type 2 diabetes also linked to specific ANK2 antecedents, the putative compounding effects of metabolic perturbation on cardiac and neurological phenotypes may pose additional risk to individuals carrying ANK2 variants. This evidence concerns the gene ANK2 and type 2 diabetes mellitus.